Adeona and National Neurovision Research Institute (NNRI) will test flupirtine in several established animal models with retinitis pigmentosa (RP) at the NNRI Preclinical Assessment Center at the Bascom
Mr Hao replaces Yu-kun Zhang, who had served as interim CFO since June, 2008. Mr Zhang is staying on as finance and accounting manager. Mr Hao has been
Clarient has previously launched its first predictive biomarker for colorectal cancer which detects mutations in the KRAS gene. Ron Andrews, CEO of Clarient, said: “In conjunction with KRAS,
Dr Vetticaden will be a member of Cubist’s executive team and report to Mike Bonney, Cubist’s president and CEO. Dr Vetticaden will lead the development and implementation of
Prospective data from the clinical study is expected to be used to support a submission to the FDA and other regulatory jurisdictions for market clearance of the 3M
The company’s Phase III clinical trial of prGCD is designed as a multi-center, randomized, double-blind, parallel group, dose-ranging trial to assess the safety and efficacy of prGCD in
According to the company, NGX267 met the primary endpoint of a statistically significant increase in salivary flow production compared to placebo at all three doses: 10mg, 15mg, and
According to the company, the Mako Tactile Guidance System (TGS) is a surgeon-interactive tactile platform that incorporates a robotic arm and patient-specific visualization technology and prepares the knee
Most recently, Dr Shannon has served as head of global development at Novartis Pharma in Basel, Switzerland. Dr Shannon has received his undergraduate and postgraduate degrees from Queen’s
Under the agreement, Mylan is provided a patent license that will enable the company to market letrozole tablets, 2.5mg, prior to the expiration of US patent. Additional terms
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.